• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Virol J . The order of infection shapes disease outcomes in influenza and herpes simplex virus coinfection by modulating immune responses

tetano

Editor, Senior Moderator
Virol J


. 2025 Oct 31;22(1):354.
doi: 10.1186/s12985-025-02968-4. The order of infection shapes disease outcomes in influenza and herpes simplex virus coinfection by modulating immune responses

Yuanjun Lyu[SUP] #[/SUP][SUP] 1 2 [/SUP], Kailin Mai[SUP] #[/SUP][SUP] 1 3 [/SUP], Hongxuan Zhou[SUP] 1 4 [/SUP], Chunguang Yang[SUP] 1 5 [/SUP], Yunceng Weng[SUP] 1 [/SUP], Zhenhui Zhang[SUP] 6 7 [/SUP], Yang Wang[SUP] 8 9 10 11 [/SUP], Zifeng Yang[SUP] 12 13 14 15 [/SUP]



Affiliations
Abstract

Background: Coinfections of influenza A virus (IAV) and herpes simplex virus type 1 (HSV-1) have been increasingly reported in patients with severe pneumonia, yet their pathogenesis remains poorly understood.
Methods: We established murine models to investigate the effects of coinfection with HSV-1 (strain KOS) and IAV (A/Aichi/2/1968 (H3N2)) under different orders of infection. Mice were assigned to one of five groups: (1) HSV-1 monoinfection, (2) H3N2 monoinfection, (3) simultaneous coinfection (H3N2 + HSV-1), (4) sequential coinfection with H3N2 administered three days prior to HSV-1 (H3N2-HSV-1), and (5) sequential coinfection with HSV-1 administered three days prior to H3N2 (HSV-1-H3N2). We then compared disease severity, viral replication, lung injury, cytokine profiles along with innate and adaptive immune responses.
Results: Overall, all coinfection groups developed more severe disease than HSV-1 monoinfection. However, when compared to H3N2 monoinfection, the order of coinfection resulted in distinct differences in disease severity and immune response patterns. Specifically, simultaneous H3N2 + HSV-1 and sequential H3N2-HSV-1 coinfections led to increased mortality, higher H3N2 viral loads, and more pronounced pulmonary inflammation. These groups exhibited elevated cytokine levels and dysregulated immune responses, with the H3N2 + HSV-1 group displaying reduced proportions of natural killer cells (NK), plasmacytoid dendritic cells (pDCs) and interferon-producing killer dendritic cells (IKDCs) in bronchoalveolar lavage fluid (BALF), while the H3N2-HSV-1 group showed a robust expansion of these innate immune cells. Additionally, these two coinfection strategies were associated with increased H3N2-specific IFN-γ⁺CD8⁺ T cells, reflecting an exacerbated adaptive response. In contrast, sequential HSV-1-H3N2 coinfection resulted in milder disease manifestations, characterized by lower mortality, decreased clinical severity, reduced cytokine levels, and diminished proportions of NK cells, pDCs, IKDCs, and CD8⁺ T cells in BALF. Moreover, H3N2-specific IFN-γ⁺CD8⁺ T cells were reduced in both lung and spleen tissues, indicating a more controlled immune activation during HSV-1-H3N2 coinfection.
Conclusion: Our study demonstrates that the infection order of H3N2 and HSV-1 coinfection critically shapes disease outcomes. Specifically, sequential H3N2 infection preceding HSV-1 or simultaneous coinfection with H3N2 and HSV-1 exacerbated immunopathology. Conversely, prior HSV-1 exposure attenuated H3N2-driven inflammation via reduced cytokine levels and immune cell recruitment. This study provides novel insights into immune dysregulation in coinfection models, with potential translational implications for managing influenza and herpesvirus coinfections.

Keywords: Coinfection; Herpes simplex virus type 1; Immune response; Influenza a virus.

 
Back
Top